Literature DB >> 12559343

Predicting pulmonary complications after pneumonectomy for lung cancer.

Francisco Javier Algar1, Antonio Alvarez, Angel Salvatierra, Carlos Baamonde, José Luis Aranda, Francisco Javier López-Pujol.   

Abstract

OBJECTIVES: Patients undergoing pneumonectomy for lung cancer are thought to be at high risk for the development of postoperative pulmonary complications (PC) and these complications are associated with high mortality rates. The purpose of this study was to identify independent factors associated with increased risk for the development of postoperative PC after pneumonectomy for lung cancer, and to assess the usefulness of predicted pulmonary function to identify high risk patients and other adverse outcomes. PATIENTS AND METHODS: We reviewed retrospectively 242 patients undergoing pneumonectomy for lung cancer during a 12-year period. Perioperative data (clinical, pulmonary function test, and surgical) were recorded to identify risk factors of PC by univariate and multivariate analyses.
RESULTS: Overall mortality and morbidity rates were 5.4 and 59%, respectively. Thirty-four patients (14%) developed PC (acute respiratory failure, ARF = 8.7%, reintubation = 5.4%, pneumonia = 3.3%, atelectasis = 2.9%, postpneumonectomy pulmonary edema = 2.5%, mechanical ventilation more than 24 h = 1.2%, pneumothorax = 0.8%). Patients with surgical (P < 0.001), cardiac (P < 0.001) and other complications (P < 0.01) had higher incidence of PC than those without postoperative complications. Intensive care unit stay (53 +/- 39 h vs. 35 +/- 19 h; P < 0.001) and hospital stay (18 +/- 11 days vs. 12 +/- 7 days; P < 0.001) was significantly longer in patients with PC. The mortality rate associated with PC was 35.5% (P < 0.001). By univariate analysis, it was found that older patients (P = 0.007), chronic obstructive pulmonary disease (COPD) (P = 0.023), heart disease (P = 0.019), no previous record of chest physiotherapy (P = 0.008), poor predicted postoperative forced expiratory volume in 1s (ppo-FEV1) (P = 0.001), and prolonged anesthetic time (P < 0.001) were related with higher risk of PC. In the multiple logistic regression model, the anesthetic time (minutes; odds ratio, OR = 1.012), ppo-FEV1 (ml/s; OR = 0.998), heart disease (OR = 2.703), no previous record of previous chest physiotherapy (OR = 2.639), and COPD (OR = 2.277) were independent risk factors of PC.
CONCLUSIONS: PC after pneumonectomy are associated with high mortality rates. Careful attention must be paid to patients with COPD and heart disease. Our results confirm the relevance of previous chest physiotherapy and the importance of the length of the surgical procedure to minimize the incidence of PC. The predicted pulmonary function (ppo-FEV1) may be useful to identify high risk patients for PC development and adverse outcomes. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Year:  2003        PMID: 12559343     DOI: 10.1016/s1010-7940(02)00719-4

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  34 in total

1.  Early respiratory acidosis is a new risk factor for pneumonia after lung resection.

Authors:  Benjamin Planquette; Françoise Le Pimpec-Barthes; Ludovic Trinquart; Guy Meyer; Marc Riquet; Olivier Sanchez
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-18

2.  Prophylactic use of noninvasive positive pressure ventilation in post-thoracic surgery patients: A prospective randomized control study.

Authors:  Guangyuan Liao; Rongchang Chen; Jianxing He
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

3.  Identifying patients at higher risk of pneumonia after lung resection.

Authors:  Gan-Wei Liu; Xi-Zhao Sui; Shao-Dong Wang; Hui Zhao; Jun Wang
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

4.  Derivation and diagnostic accuracy of the surgical lung injury prediction model.

Authors:  Daryl J Kor; David O Warner; Anas Alsara; Evans R Fernández-Pérez; Michael Malinchoc; Rahul Kashyap; Guangxi Li; Ognjen Gajic
Journal:  Anesthesiology       Date:  2011-07       Impact factor: 7.892

5.  Predicting risk of postoperative lung injury in high-risk surgical patients: a multicenter cohort study.

Authors:  Daryl J Kor; Ravi K Lingineni; Ognjen Gajic; Pauline K Park; James M Blum; Peter C Hou; J Jason Hoth; Harry L Anderson; Ednan K Bajwa; Raquel R Bartz; Adebola Adesanya; Emir Festic; Michelle N Gong; Rickey E Carter; Daniel S Talmor
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

Review 6.  [Consequences of pneumonectomy in the early and late phases].

Authors:  R A Hatz; L V Klotz
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

7.  Survival rate and prognostic factors of surgically resected clinically synchronous multiple primary non-small cell lung cancer and further differentiation from intrapulmonary metastasis.

Authors:  Fei Xiao; Deruo Liu; Yongqing Guo; Bin Shi; Zhiyi Song; Yanchu Tian; Zhenrong Zhang; Chaoyang Liang
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

8.  Effectiveness of intervention with a perioperative multidisciplinary support team for radical esophagectomy.

Authors:  Yuji Akiyama; Takeshi Iwaya; Fumitaka Endo; Yoshihiro Shioi; Motoi Kumagai; Takeshi Takahara; Koki Otsuka; Hiroyuki Nitta; Keisuke Koeda; Masaru Mizuno; Yusuke Kimura; Kenji Suzuki; Akira Sasaki
Journal:  Support Care Cancer       Date:  2017-06-28       Impact factor: 3.603

9.  Noninvasive ventilation for acute respiratory failure after lung resection: an observational study.

Authors:  Aurélie Lefebvre; Christine Lorut; Marco Alifano; Hervé Dermine; Nicolas Roche; Rémy Gauzit; Jean-François Regnard; Gérard Huchon; Antoine Rabbat
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

10.  UK pneumonectomy outcome study (UKPOS): a prospective observational study of pneumonectomy outcome.

Authors:  Ellie S Powell; Adrian C Pearce; David Cook; Paul Davies; Ehab Bishay; Geoffrey M R Bowler; Fang Gao
Journal:  J Cardiothorac Surg       Date:  2009-07-30       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.